SCHEMBL733422

SCHEMBL733422

COc1cc(-c2ccc(C(C)C(O)(c3ccc(=O)n(C)c3)C(F)(F)F)c(Cl)c2)ccc1C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.35
RORC P51449 1/20 0.34
CHEK1 O14757 1/20 0.34
ADRB3 P13945 3/20 0.33
ADRB1 P08588 2/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
DPP4 P27487 3/20 0.33
DPP7 Q9UHL4 3/20 0.33
F11 P03951 1/20 0.33
KDM4E B2RXH2 2/20 0.32
APAF1 O14727 1/20 0.32
RECQL P46063 1/20 0.32
CASP6 P55212 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
MCL1 Q07820 1/20 0.32
CASP8 Q14790 1/20 0.32
ALDH1A1 P00352 2/20 0.32
PPARG P37231 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL755590 1.00 ESR1 (0.35) ESR1RORCCHEK1ADRB3ADRB1
SCHEMBL754904 0.92 PDK2 (0.36) CHEK1AKR1C3AKR1C2DPP4DPP7
SCHEMBL734838 0.92 PDK2 (0.36) CHEK1AKR1C3AKR1C2DPP4DPP7
SCHEMBL734223 0.91 PDK2 (0.36) RORCAKR1C2DPP4DPP7
SCHEMBL755587 0.91 PDK2 (0.36) RORCAKR1C2DPP4DPP7
SCHEMBL754911 0.90 ESR1 (0.35) ESR1RORCCHEK1ADRB3ADRB1
SCHEMBL734058 0.90 ESR1 (0.35) ESR1RORCCHEK1ADRB3ADRB1
SCHEMBL15789711 0.89 THRB (0.33) AKR1C3AKR1C2DPP4DPP7F11
SCHEMBL755583 0.88 DPP4 (0.34) RORCAKR1C2DPP4DPP7F11
SCHEMBL732428 0.88 DPP4 (0.34) RORCAKR1C2DPP4DPP7F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP claimed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US claimed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US claimed
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 ESR1 390/4885RORC 250/4885CHEK1 4597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.